SG235-TRAIL, an adenovirus holding an Ad5/F35 chimeric fibre and engineered with an antitumor gene TRAIL, operated with homoharringtonine in leukemia cell lines with a synergistic effect [106]. This evidence concerns the gene TNFSF10 and leukemia.